ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
143 hedge funds and large institutions have $389M invested in iTeos Therapeutics in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 58 increasing their positions, 48 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
1% less funds holding
Funds holding: 145 → 143 (-2)
16% less capital invested
Capital invested by funds: $460M → $389M (-$71.8M)
Holders
143
Holding in Top 10
2
Calls
$7.51M
Puts
$3.25M
Top Buyers
| 1 | +$7.92M | |
| 2 | +$5.48M | |
| 3 | +$4.06M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$3.93M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.79M |
Top Sellers
| 1 | -$6.04M | |
| 2 | -$5.41M | |
| 3 | -$3.83M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$3.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.06M |